Aperio Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$2.8M Sell
161,134
-2,949
-2% -$47.1K 0.01% 1079
2020
Q3
$2.26M Buy
164,083
+24,199
+17% +$355K 0.01% 1065
2020
Q2
$2.02M Sell
139,884
-4,841
-3% -$63.6K 0.01% 1113
2020
Q1
$1.58M Sell
144,725
-49,957
-26% -$921K 0.01% 1116
2019
Q4
$4.16M Sell
194,682
-12,569
-6% -$281K 0.01% 810
2019
Q3
$4.76M Buy
207,251
+36,140
+21% +$771K 0.02% 723
2019
Q2
$3.37M Buy
171,111
+16,079
+10% +$313K 0.01% 853
2019
Q1
$3.02M Buy
155,032
+12,806
+9% +$243K 0.01% 873
2018
Q4
$2.34M Buy
142,226
+24,632
+21% +$496K 0.01% 919
2018
Q3
$2.72M Buy
117,594
+49,369
+72% +$1.12M 0.01% 893
2018
Q2
$1.48M Buy
68,225
+22,865
+50% +$447K 0.01% 1171
2018
Q1
$801K Sell
45,360
-11,643
-20% -$205K ﹤0.01% 1449
2017
Q4
$1.07M Sell
57,003
-113,944
-67% -$2.27M 0.01% 1264
2017
Q3
$3.75M Buy
170,947
+148,810
+672% +$3.36M 0.02% 702
2017
Q2
$534K Buy
22,137
+2,303
+12% +$58.6K ﹤0.01% 1615
2017
Q1
$554K Buy
19,834
+137
+0.7% +$3.59K ﹤0.01% 1486
2016
Q4
$481K Sell
19,697
-1,780
-8% -$40.8K ﹤0.01% 1537
2016
Q3
$541K Buy
21,477
+263
+1% +$6.3K ﹤0.01% 1408
2016
Q2
$438K Sell
21,214
-1,156
-5% -$24.1K ﹤0.01% 1461
2016
Q1
$449K Buy
22,370
+9,343
+72% +$179K ﹤0.01% 1421
2015
Q4
$264K Buy
13,027
+1,270
+11% +$26.7K ﹤0.01% 1693
2015
Q3
$273K Buy
+11,757
New +$300K ﹤0.01% 1611
2015
Q2
Sell
-10,254
Closed -$340K 2034
2015
Q1
$340K Buy
10,254
+2,294
+29% +$74.4K ﹤0.01% 1488
2014
Q4
$242K Buy
+7,960
New +$219K ﹤0.01% 1636

Other funds holding SBRA

Aperio Group's SBRA Position: Q4 2020 in Review

Aperio Group reduced its Sabra Healthcare REIT (SBRA) stake by 1.8% in Q4 2020, selling an estimated $47.1K and leaving 161,134 shares worth $2.8M. The position accounts for 0.01% of the portfolio, ranked #1079.

Aperio Group first reported a position in SBRA in Q4 2014 and has held it in 24 quarters since. The position peaked at $4.76M in Q3 2019. 322 funds tracked by Wall St. Rank hold SBRA as of Q4 2020.

  • Aperio Group held 161,134 shares of Sabra Healthcare REIT worth $2.8M as of Q4 2020.
  • Aperio Group sold 2,949 Sabra Healthcare REIT shares in Q4 2020, an estimated $47.1K.
  • Sabra Healthcare REIT made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1079 holding.
  • Aperio Group first reported a position in Sabra Healthcare REIT in Q4 2014 and has held it in 24 quarters since.
  • Aperio Group's Sabra Healthcare REIT position peaked at $4.76M in Q3 2019.
  • 322 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.